GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » ROE % Adjusted to Book Value

Serina Therapeutics (Serina Therapeutics) ROE % Adjusted to Book Value : 0.00% (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Serina Therapeutics ROE % Adjusted to Book Value?

Serina Therapeutics's ROE % for the quarter that ended in Mar. 2024 was 0.00%. Serina Therapeutics's PB Ratio for the quarter that ended in Mar. 2024 was N/A. Serina Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was N/A.


Serina Therapeutics ROE % Adjusted to Book Value Historical Data

The historical data trend for Serina Therapeutics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Serina Therapeutics ROE % Adjusted to Book Value Chart

Serina Therapeutics Annual Data
Trend Dec21 Dec22
ROE % Adjusted to Book Value
- -

Serina Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Mar24
ROE % Adjusted to Book Value - - - Negative Equity -

Competitive Comparison of Serina Therapeutics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Serina Therapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Serina Therapeutics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Serina Therapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Serina Therapeutics's ROE % Adjusted to Book Value falls into.



Serina Therapeutics ROE % Adjusted to Book Value Calculation

Serina Therapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Serina Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Serina Therapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Serina Therapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Serina Therapeutics (Serina Therapeutics) Business Description

Comparable Companies
Traded in Other Exchanges
Address
601 Genome Way, Suite 2001, Huntsville, AL, USA, 35806
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

Serina Therapeutics (Serina Therapeutics) Headlines